News

The nature versus nurture debate has a new talking point, with research into the role of the epigenome in non-genetic disease inheritance.…  Read more

A long-awaited treatment for a common cause of cancer is a big step closer thanks to Federal Government NHMRC funding – offering hope that naturally occurring nanoparticles will be the missing link for treating chronic liver disease.…  Read more

A biomedical team based at Hudson Institute has received sought-after funding to pursue new international interdisciplinary RNA research cooperation.…  Read more

Ovarian cancer specialists have taken a novel path to advance their research – tapping into an international Facebook group to learn from members’ experiences.…  Read more

The discovery of a new class of host-targeted therapy could give the medical profession a much-needed treatment option for serious flu infections.…  Read more

Hudson Institute researchers have conducted the first attempts to collect umbilical cord blood cells from very preterm babies, with a view to using them to reduce their increased risk of brain injury and disability.…  Read more

A single laboratory in south-east Melbourne is now the global hub for medical researchers looking to cure childhood cancer.…  Read more

Keeping T cells active, but not too active, could be the key to new potential immune therapies, according to the latest research.…  Read more

Hudson Institute’s endometriosis research was in focus on Melbourne radio over the weekend, as long-running science program Einstein A-Go-Go devoted its whole hour to the disease.…  Read more

Two leading Hudson Institute researchers are taking their discoveries closer to the clinic and bringing better health to the lives of preterm babies and Australians with hypertension, thanks to significant new funding.…  Read more